FDA approves emergency use authorization for at-home COVID-19 test

Published



The Food and Drug Administration approved an emergency use authorization for an at-home coronavirus test.

The FDA authorized LabCorp’s Pixel COVID-19 Test Home Collection Kit, a direct-to-consumer testing kit that allows users to collect a nasal swab sample at home and mail it to LabCorp for testing, according to a press release. Users are notified of positive results via telephone from a healthcare provider, and negative results are delivered in an email.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.